McCool D J, Forstner J F, Forstner G G
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
Biochem J. 1995 Nov 15;312 ( Pt 1)(Pt 1):125-33. doi: 10.1042/bj3120125.
We have shown previously [McCool, Forstner and Forstner (1994) Biochem. J. 302, 111-118] using pulse-chase labelling of mucin with [3H]threonine that LS180 colonic tumour cells synthesize and secrete MUC2 without the addition of secretagogues. Treatment of the LS180 cells with monensin to disrupt Golgi function was also found to inhibit baseline secretion almost completely. In this paper we show that addition of nocodazole to inhibit microtubule assembly reduced baseline secretion by 53% over a 6 h chase period. In contrast, cytochalasin D did not affect the rate of unstimulated mucin synthesis or secretion, suggesting that baseline secretion is not influenced by disruption of actin microfilaments. In addition, regulated mucin secretion by LS180 cells was studied in response to carbachol, phorbol 12-myristate 13-acetate and A23187. Mucin released in response to secretagogues behaved identically on SDS/PAGE to that secreted under baseline conditions. T84 cells and the B6 subclone of the HT29 cell line responded in a similar manner to LS180 cells and secreted high-molecular-mass mucin which included MUC2 and behaved like LS180 mucin on SDS/PAGE. Neither monensin nor nocodazole significantly affected secretagogue-stimulated mucin secretion. Since these compounds inhibited secretion of labelled mucin under baseline conditions, mucin released by secretagogues must have come from a separate, unlabelled mucin pool in stored granules. Cytochalasin D, on the other hand, caused the release of small amounts of stored mucin, suggesting that actin microfilaments participate in regulated exocytosis. Thus two kinds of mucin secretion occur in LS180 cells. Unregulated secretion depends upon continuous transport of mucin granules from Golgi vesicles to the cell surface and does not utilize stored mucin, whereas regulated secretion involves the release of mucin from storage granules and is not affected by microtubule or Golgi disruption.
我们之前已经证明[麦库尔、福斯特纳和福斯特纳(1994年),《生物化学杂志》302卷,第111 - 118页],使用[³H]苏氨酸对粘蛋白进行脉冲追踪标记,LS180结肠肿瘤细胞在不添加促分泌剂的情况下合成并分泌MUC2。还发现用莫能菌素处理LS180细胞以破坏高尔基体功能几乎能完全抑制基础分泌。在本文中我们表明,添加诺考达唑以抑制微管组装在6小时的追踪期内使基础分泌减少了53%。相比之下,细胞松弛素D不影响未刺激的粘蛋白合成或分泌速率,这表明基础分泌不受肌动蛋白微丝破坏的影响。此外,研究了LS180细胞对卡巴胆碱、佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯和A23187的调节性粘蛋白分泌。对促分泌剂作出反应而释放的粘蛋白在SDS/聚丙烯酰胺凝胶电泳上的表现与在基础条件下分泌的粘蛋白相同。T84细胞和HT29细胞系的B6亚克隆对LS180细胞的反应方式相似,分泌高分子量粘蛋白,其中包括MUC2,并且在SDS/聚丙烯酰胺凝胶电泳上的表现与LS180粘蛋白相似。莫能菌素和诺考达唑均未显著影响促分泌剂刺激的粘蛋白分泌。由于这些化合物在基础条件下抑制标记粘蛋白的分泌,促分泌剂释放的粘蛋白必定来自储存颗粒中一个单独的、未标记的粘蛋白池。另一方面,细胞松弛素D导致少量储存粘蛋白的释放,这表明肌动蛋白微丝参与调节性胞吐作用。因此,LS180细胞中发生两种粘蛋白分泌。非调节性分泌依赖于粘蛋白颗粒从高尔基体囊泡持续转运到细胞表面,且不利用储存的粘蛋白,而调节性分泌涉及从储存颗粒中释放粘蛋白,并且不受微管或高尔基体破坏的影响。